CLINICAL_TRIALS trial_result · 2025-09-19

Clinical Trial Update: Intranasal Vasopressin Treatment in Children With Autism [Phase 2, Phase 3]

A phase 2/3 clinical trial investigating intranasal vasopressin for autism spectrum disorder in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Stanford University | Conditions: Autism, Autism Spectrum Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-09-19